Werner Heilmayer

Vice President-CMC & IP at Nabriva Therapeutics AG

Werner Heilmayer

Werner Heilmayer

Vice President-CMC & IP at Nabriva Therapeutics AG

Biography

Werner Heilmayer joined Nabriva Therapeutics in February 2006. Having worked for almost 20 years in the pharmaceutical and biotech industry, Werner has gained significant experience in drug development and intellectual property. He has a strong track record in patent filing and is co-inventor of more than 10 international filed patent applications. Before joining Nabriva, Werner was the Head of Chemistry of Sandoz's discovery unit. Werner played a major role in the Nabriva spin-off from Sandoz and served Nabriva as Head of Chemistry, Manufacturing, Controls and Intellectual Property before he was appointed Vice President in June 2012. He holds a PhD in Organic Chemistry.

Overview
RelSci Relationships

27

Relationships
RelSci Relationships are individuals Werner Heilmayer likely has professional access to. A relationship does not necessarily indicate a personal connection.

Chief Financial Officer at F2G Ltd.

Relationship likelihood: Strong

Former Vice President & Head, Clinical Pharmacology Experimental Medicine at GlaxoSmithKline Plc

Relationship likelihood: Strong

Former Director & Chief Executive Officer at Nabriva Therapeutics Plc

Relationship likelihood: Strong

Chief Information Officer at Nabriva Therapeutics AG

Relationship likelihood: Strong

Corporate Secretary & General Counsel at Nabriva Therapeutics AG

Relationship likelihood: Strong

President & Chief Operating Officer at Nabriva Therapeutics Plc

Relationship likelihood: Strong

Senior Vice President-Clinical Development at UroGen Pharma Ltd.

Relationship likelihood: Strong

Vice President, Commercial Strategy & Access at Nabriva Therapeutics AG

Relationship likelihood: Strong

Vice President, Quality at Nabriva Therapeutics AG

Relationship likelihood: Strong

Chief Commercial Officer at Nabriva Therapeutics Plc

Relationship likelihood: Strong

Paths to Werner Heilmayer
Potential Connections via
Relationship Science
You
Werner Heilmayer
Vice President-CMC & IP at Nabriva Therapeutics AG
Career History
Vice President-CMC & IP
2006 - Current

Nabriva Therapeutics AG is a clinical-stage biopharmaceutical company. It engages in the research and development of novel antibiotics to treat infections, with a focus on the pleuromutilin class of antibiotics. The company was founded by Rodger Novak in October 2005 and is headquartered in Vienna, Austria.

Vice President, Chemistry, Manufacturing, Controls & Intellectual Property
Tenure Unconfirmed

Nabriva Therapeutics Plc is a clinical stage biopharmaceutical company, which engages in the research and development of novel antibiotics to treat serious infections. Its lead product candidate, lefamulin, is a pleuromutilin antibiotic available for systemic administration in humans. It develops intravenous and oral formulations of lefamulin for the treatment of community-acquired bacterial pneumonia and intends to develop lefamulin for additional indications other than pneumonia. The company was founded in October, 2017 and is headquartered in Dublin, Ireland.

Other Affiliations

Werner Heilmayer is affiliated with Nabriva Therapeutics AG, Nabriva Therapeutics Plc

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Werner Heilmayer. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Werner Heilmayer's profile does not indicate a business or promotional relationship of any kind between RelSci and Werner Heilmayer.